Citalopram
- Generic Name
- Citalopram
- Brand Names
- Celexa, Ctp
- Drug Type
- Small Molecule
- Chemical Formula
- C20H21FN2O
- CAS Number
- 59729-33-8
- Unique Ingredient Identifier
- 0DHU5B8D6V
- Background
Citalopram is an antidepressant belonging to the class of selective serotonin-reuptake inhibitors (SSRIs) widely used to treat the symptoms of depression. It is a racemic bicyclic phthalate derivate and is the only compound with a tertiary amine and 2 nitrogen-containing metabolites among all SSRIs. Citalopram enhances serotonergic transmission through the i...
- Indication
Citalopram is approved by the FDA for treating adults with major depressive disorder. It has also been used off-label to treat various diseases, including but not limited to sexual dysfunction, ethanol abuse, psychiatric conditions such as obsessive-compulsive disorder (OCD), social anxiety disorder, panic disorder, and diabetic neuropathy.
- Associated Conditions
- Alcohol Abuse, Anorexia Nervosa (AN), Binge Eating Disorder (BED), Bulimia Nervosa, Depression, Diabetic Neuropathies, Generalized Anxiety Disorder, Major Depressive Disorder (MDD), Obsessive Compulsive Disorder (OCD), Panic Disorder, Post Traumatic Stress Disorder (PTSD), Premature Ejaculation, Premenstrual Dysphoric Disorder (PMDD), Separation Anxiety Disorder, Social Anxiety Disorder (SAD)
- Associated Therapies
- -
A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression
- Conditions
- Interventions
- First Posted Date
- 2008-04-25
- Last Posted Date
- 2010-06-15
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 750
- Registration Number
- NCT00666757
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Brown Deer, Wisconsin, United States
Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2012-10-08
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 12
- Registration Number
- NCT00609531
- Locations
- 🇺🇸
UNC-Chapel Hill, Chapel Hill, North Carolina, United States
Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With Depression
- Conditions
- Interventions
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-11
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 181
- Registration Number
- NCT00602290
- Locations
- 🇺🇸
UCLA Semel Institute - Neuropsychiatric Institute (NPI), Los Angeles, California, United States
Dementia Antipsychotics And Antidepressants Discontinuation Study
- Conditions
- Interventions
- First Posted Date
- 2008-01-15
- Last Posted Date
- 2011-02-23
- Lead Sponsor
- Sykehuset Innlandet HF
- Target Recruit Count
- 149
- Registration Number
- NCT00594269
- Locations
- 🇳🇴
Sykehuset Innlandet HF, Reinsvoll, Oppland, Norway
🇳🇴Diakonihjemmets Hospital, Oslo, Norway
🇳🇴Ullevaal University Hospital, Oslo, Norway
Study Evaluating a Combined Administration of Lecozotan SR and Citalopram in Young Healthy Subjects
- Conditions
- First Posted Date
- 2007-10-03
- Last Posted Date
- 2007-12-11
- Lead Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Target Recruit Count
- 40
- Registration Number
- NCT00538889
Citalopram in Irritable Bowel Syndrome
- First Posted Date
- 2007-05-22
- Last Posted Date
- 2017-04-17
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 54
- Registration Number
- NCT00477165
- Locations
- 🇺🇸
UCSF, San Francisco, California, United States
Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD
- Conditions
- Interventions
- First Posted Date
- 2007-02-09
- Last Posted Date
- 2007-08-24
- Lead Sponsor
- Sykehuset Innlandet HF
- Target Recruit Count
- 24
- Registration Number
- NCT00433121
- Locations
- 🇳🇴
Sykehuset Innlandet HF - Sanderud, Ottestad, Oppland, Norway
Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia
- Conditions
- First Posted Date
- 2006-09-14
- Last Posted Date
- 2017-05-05
- Lead Sponsor
- Sunnybrook Health Sciences Centre
- Target Recruit Count
- 22
- Registration Number
- NCT00376051
- Locations
- 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
🇨🇦The Baycrest Centre for Geriatric Care, Toronto, Ontario, Canada
STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse
- First Posted Date
- 2006-08-29
- Last Posted Date
- 2014-05-09
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 674
- Registration Number
- NCT00369746
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
- Conditions
- First Posted Date
- 2006-07-13
- Last Posted Date
- 2011-01-26
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 494
- Registration Number
- NCT00351910
- Locations
- 🇸🇪
Research Site, Uppsala, Sweden
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.